37
Participants
Start Date
August 4, 2022
Primary Completion Date
September 5, 2025
Study Completion Date
September 10, 2025
Placebo
Placebo will be administered by intravenous (IV) infusion.
AOC 1001
AOC 1001 will be administered by intravenous (IV) infusion.
University of Rochester Medical Center, Rochester
Virginia Commonwealth University, Richmond
University of Florida, Gainesville
Ohio State University, Columbus
Kansas University Medical Center, Kansas City
University of Colorado, Denver
University of California Los Angeles, Los Angeles
Stanford University, Palo Alto
Lead Sponsor
Avidity Biosciences, Inc.
INDUSTRY